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Abstract
Background: To evaluate the value of a pre-ordering process for the pro-active scheduling and completion of
appropriate preventive and chronic disease monitoring tests prior to a periodic health examination (PHE).
Methods: A standardized template was developed and used by our nursing staff to identify and schedule
appropriate tests prior to the patients PHE. Chart reviews were completed on all 602 PHE visits for a 3-month
interval in a primary care setting. A patient satisfaction survey was administered to a convenience sample of the
PHE patients.
Results: Of all the patients with tests pre-ordered, 87.8% completed the tests. All providers in the division used the
process, but some evolved from one template to another over time. Most patients (61%) preferred to get their
tests done prior to their PHE appointment. Many of our patients had abnormal test results. With this process,
patients were able to benefit from face-to-face discussion of these results directly with their provider.
Conclusions: A pre-order process was successfully implemented to improve the value of the PHE visit in an
internal medicine primary care practice using a standardized approach that allowed for provider autonomy. The
process was accepted by patients and providers and resulted in improved office efficiency through reduced
message handling. Completion of routine tests before the PHE office visit can help facilitate face-to-face
discussions about abnormal results and subsequent management that otherwise may only occur by telephone.
Background
Patients clearly benefit from preventive services. Some
preventive services, such as immunization, can reduce
disease risk. Other preventive services, such as cancer
screenings, can provide early detection and curative
treatment. The success of preventive services in improv-
ing the health of patients has made the delivery of these
services a top priority of healthcare in the US. Preven-
tive services were prominently displayed as examples of
underused services by the Institute of Medicine’s (IOM)
landmark book “Crossing the Quality Chasm”[1] The
IOM challenged the nation to improve the delivery of
preventive service. A dilemma medical practices face is
how to deliver the myriad of recommended preventive
services efficiently. It is clear that physicians lack the
time to do it all. Studies estimate that the time required
to deliver all the recommended preventive services to a
normal panel size of 2,500, ranges from 8 to 22 hours
daily [2,3]. A systems approach to this problem has
been partially successful [4]. At Mayo Clinic’s campus in
Rochester, MN systems approaches to mammography
screening and osteoporosis screening have resulted in
significant improvements in care delivery to patients
without requiring physician contact [5,6]. Other compu-
terized reminder systems help increase attention to pre-
ventive services at the point of care [7].
Despite some success of automated systems to
improve the delivery of preventive services, there is suf-
ficient evidence to suggest that providers should still be
playing an active role in the process. In addition to the
evaluation of underlying concerns and chronic disease
management, the PHE also identifies and rectifies gaps
in recommended preventive services. The PHE is
intended to provide the time necessary for education,
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tematic review on the PHE came to the conclusion that
it improved the delivery of some recommended preven-
tive services [8]. Another recent study confirmed that
the PHE improves delivery of cancer screening [9].
The standard practice of identifying and ordering
screening and chronic disease monitoring tests at the
PHE office visit is not satisfying or efficient. Valuable
provider time is expended identifying and ordering tests.
Prior to implementation of the PHE pre-order process,
the standard practice was for the provider to identify
and order preventive services at the time of the PHE.
To improve appointment capacity for necessary face-to-
face visits, the division eliminated routine return visits
for test results in 2002. Patients are now notified of rou-
tine test results generated from a PHE visit via tele-
phone calls from the provider or nursing staff, or by a
letter sent to them in the mail. On a previous internal
audit at the Mayo Clinic, we determined that call backs
for test results can be extremely time consuming,
requiring an average of 7.5 messages back and forth
between the nurse, provider, and patient, before patients
are informed of the result. Likewise, a letter takes sev-
eral minutes to complete and has additional stationary
and postal expense. Patients also have strong prefer-
ences for how they like to receive test results, and they
prefer their own doctor inform them of their results
[10].
We wanted to improve the efficiency of the PHE pro-
cess by implementing a system to pro-actively identify,
order, and schedule appropriate services prior to a PHE.
Our aim was to improve the value of the PHE by order-
ing and obtaining preventive and chronic disease moni-
toring tests prior to the PHE so the results would be
available for discussion at the time of the office visit.
We also wanted to assess the acceptability of this pro-
cess to patients who would get their testing completed
at a different time from their PHE appointment, often
requiring an extra visit. Herein, we recount our experi-
ence with development and implementation of the pro-
cess to accomplish these aims.
Methods
The study took place in the Division of Primary Care
Internal Medicine (PCIM) at Mayo Clinic, Rochester,
M i n n e s o t a .A tt h et i m eo ft h es t u d y ,t h e r ew e r e4 1
internists in PCIM who were split into smaller care
teams staffed with 5 to 6 physicians, 1 Nurse Practi-
tioner or Physician’s Assistant, 2 to 3 patient appoint-
ment coordinators (PAC), 3 licensed practical nurses
(LPN), and 3 registered nurses (RN). The division serves
42,000 patients and managed over 88,000 office visits in
2009. All patients served by the division are age fifteen
or older. This study was reviewed by the Mayo Clinic
Institutional Review Board (Application number- 10-
000383). The Board determined the study involved a
quality assurance project and did not constitute research
involving human subjects.
Most appointments for a PHE are requested by the
patient who desires a comprehensive medical evaluation.
Some appointments are requested by the primary care
provider for patients with chronic diseases that would
benefit from a comprehensive PHE. The pre-orders pro-
cess was limited to PHE appointments, which were
scheduled at least 2 weeks in advance. We created a
standard template that outlined preventive service
recommendations based on the Institute for Clinical
Systems Improvement (ICSI) guidelines (Figure 1).(ISCI
website; http://www.icsi.org) Providers were allowed to
modify the standard template and create a provider spe-
cific template to fit individual practice styles for addi-
tional testing as long as established guidelines continued
to be followed for routine services. In each of the care
teams, a licensed practical nurse (LPN) was trained to
use the template to identify and order indicated preven-
tive services tests before a scheduled PHE. PAC staff
was trained to offer pre-ordering when a patient called
b yt e l e p h o n et os c h e d u l eaP H Ev i s i ta n dt h ee l e c t r o n i c
record indicated services were due. Training was pro-
vided to LPN staff about evidence based preventive
screening and chronic disease monitoring consistent
with ICSI guidelines. Several mock patients were
reviewed with provider and LPN staff to assist in LPN
training and assure accurate ordering. Prior to the PHE
visit, the nurse would review the patient’s medical
record and order the indicated tests. With the standar-
dized template, the nurse examined the record for speci-
fic chronic diseases (hypertension, diabetes,
hyperlipidemia, etc.) and the ordering of standard tests
to follow these conditions was done by protocol. The
standard template also contained protocols for ordering
cancer related screening. Customized templates had
minor individual provider variations to the standard. For
example, some providers wanted AST or ALT levels for
all their patients getting lipid panels. Others wanted
fasting glucose levels on all patients, and some wanted
mammograms continued beyond age 75. All lab tests
were scheduled to be completed within 7 days of the
scheduled office visit. We termed this the PHE pre-
order process.
Each provider was given basic instructions on how the
process worked and how the LPN could pre-order tests
prior to a scheduled PHE. For each provider, the pre-
orders process was strictly voluntary. Providers were
free to decline the pre-orders process for their PHE
appointments from the very start or stop using it at any
time. Providers had the option of using either the stan-
dard or a customized template and could either
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Page 2 of 8    Patient Name: ____________________               Provider___________________________________ 
     Clinic Number: ___________________   
     Age: _______ 
  Circle: F emale/Male 
  Physician: _______________________       
  GME date scheduled: ________________ 
  S chedule 2 weeks out or longer 
  Preferred date to Schedule tests- 
   _____________________ 
   Return to: _______________ by _____________ 
 
Chronic Disease  Care Team LPN or 
Provider to complete 
Notes 
 
  Thyroid disease, any 
 
 TSH 
Indication __________ 
 
 
 Hypertension, any 
 
 Creatinine            Sodi um 
 Potassium            Indication _________ 
 
 Lipid disorder, any 
 
 
 Lipid Screen          Indication ________ 
 
 Diabetes 
 
 
 
 
 Glucose                       Hemoglobin A1c   
 Lipid Screen                Creatinine             
 Microalbumin, random urine                     
                                      Indication =Diabetes 
 
 
 Impaired Fast. Glucose 
     Hyperglycemia 
     Glucose Intolerance 
 
 Glucose 
 
Indication____________ 
 
 CAD 
 
 Lipid P rofile    
 
 Drug Levels 
 
 Digoxin 
 Sei zu r e M edi cat i on  
 MGUS  (Monoclonal 
Gammopathy of Undetermined 
S ignificance) 
 
 SPEP ( Ser um Pr otei n El ectr ophor esi s)  
 
 
 
 
Preventive Services  Notes 
 
 Mammogram (Ages 40-75) 
 
Indication = Screening 
 
 Lipid S creen (ages 35-75 for men; ages 
45-75 for women; every 5 years if normal) 
Indication __________ 
 PSA Total (if h/ o prostate CA) 
 BMD (after age 65) 
Indication __________ 
 
 
Comments: 
Medicare Covered Indications   
 
TSH= Hypothyroidis m, primary    BMD = Osteoporosis 
Screening 
          Medication Rx long-term      Menopause   
          Nodule, thyroid        Osteopenia 
          Thyroid dysfunction      Osteoporosis 
 
 
Lipid Screen= Hyperlipidemia    Glucose = DM 
           Hypertension    Hyperglycemia 
                       CAD      Imp Fasting Glucose 
           DM1 
           DM2 
           Congestive heart failure 
Figure 1 Pre-orders template used by allied health staff to determine what tests to order for a patient before a PHE visit.
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Page 3 of 8complete the template themselves or have the LPN
complete it. Providers also had the option to review the
templates once they were completed by the LPN.
We collected data from 602 pre-orders templates
initiated from June 15, 2009 through July 30, 2009 for
patients who had requested a PHE. Chart review was
performed for all 602 of those patients. Data collected
from the pre-order template was the clinic number, date
of template initiation, provider name, LPN name, and
number of tests ordered prior to the PHE. For the pur-
poses of the study, a test orderable as a bundled item
was counted as one test. For example, a lipid panel was
counted as one test, even though it included triglycer-
ides, HDL, LDL, and total cholesterol values. A test was
considered abnormal if the laboratory flagged the result
as such. Data collected from chart review was the date
of the PHE, and number of tests ordered on the date of
the PHE.
A convenience sample of 44 office visit patients to
PCIM were asked about their preferences for PHE
testing.
The 7 LPNs who used the pre-orders templates identi-
fied the provider’s use of the preorders templates (stan-
dard vs. custom) in 2008 and how they were using it in
2009 at the time of the study. The nurses also tracked
the time spent to complete the preorders tasks of chart
review and ordering tests.
We used JMP 8.01 (SAS Institute, Cary, NC) for the
descriptive statistics and data analysis. The T-test was
used to calculate the p value for the difference in means
of the number of tests ordered.
Results
Females accounted for 374 (62%) of the pre-orders. The
mean age for all patients with pre-orders was 61.8 years
(CI 95% = 60.5 to 63.0%).
All providers in the division used the process (41/41).
At initiation of the study, the standard template was
used by 11 (26.8%) of the providers, while the other 30
(73.2%) providers elected to add specific orders to the
standard template, therefore, establishing a customized
template to correspond to their individual practice
styles.
Nursing time to do the pre-orders depended on the
degree of involvement of the provider in the process.
For those providers who allowed the LPN to accom-
plish the preorders process independently (without
direct provider input), it took the LPN 6.78 minutes
(CI 95% = 6.38 to 7.19, N = 356) to review the patients
chart and issue indicated orders. For those providers
who desired more direct input into the process it took
the LPN 4.44 minutes (CI 95% = 3.64 to 5.24, N = 97)
to review a patients chart and prepare the appropriate
template for the provider review. The time difference
was due to the LPN not placing orders before provider
review.
An earlier pilot of this process resulted in a 69%
reduction in message handling and a 40% reduction in
the days it took to communicate test results to the
patient. (Figure 2)
The patient survey showed a majority of patients pre-
ferred getting studies completed before the PHE. For
the question “Do you prefer to have tests completed
before your appointment?”,2 7p a t i e n t sa n s w e r e d“yes”
(61%, CI 95% = 47% to 74%), while 15 (34%, CI 95% =
22% to 49%) answered “don’t care”. A 5-category Likert
scale question “It is important to me that, before my
examination, I have appropriate tests completed ahead
of time so results are available for discussion face-to-
face with my provider”,r e s u l t e di n“strongly agree” or
“agree” for 29 patients (65.9%, CI 95%= 51% to 80%).
(Figure 3)
Of the 602 patients who had an appointment for a
PHE, with the pre-orders process, 590 (98%) attended
the appointment. A total of 2082 total tests were preor-
dered for these patients. Tests were pre-ordered for
76.1% (CI 95% = 75.5% to 79.3%) of these patients. Nur-
sing pre-ordered a mean number of 3.46 (CI 95%= 3.7
to 3.2) tests per patient (Figure 4). Of all the patients
with tests pre-ordered, 87.8% (CI = 84.5-90.5) completed
the tests.
Of the 602 total patients that had a periodic health
maintenance visit scheduled, 277 had abnormal lab
results (46%). The mean number of abnormal lab results
for each patient was 0.86 (CI 95% = .77 to.95). Of the
458 patients that had pre-ordered labs, 277 had at least
one abnormal lab results (61.0%; CI 95% = 56.4 to 65.4).
For this 61%, this provided an opportunity for a face-to-
face discussion of these abnormal results with provider.
There were a total of 509 abnormal results out of 458
patients.
Of the patients that attended the appointment, 71%
had additional tests or consults ordered on the day of
the visit. There were 196 patients (33.2%; CI 29.5 to
37.1) who had consultations ordered and, 1419 total
tests were ordered on the day of the office visit out of a
total of 590 patients that attended the appointment.
Additional blood tests ordered at the office visit can
often be done with stored serum, therefore, eliminating
the need for another venipuncture. Our laboratory
stores serum for 7 days after a blood draw. A mean of
2.4 (CI = 2.67-2.13) total additional orders were issued
per patient by the provider on the day of the visit.
Patients with no tests pre-ordered (N = 144) had signifi-
cantly more tests ordered at the time of examination
(mean = 3.08, 95%CI 2.62 to 3.55) than those who had
tests preordered (mean tests ordered examination day =
2.20, 95% CI 1.94 to 2.46). This represented a 0.88
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Figure 2 Pre-intervention and post-intervention distribution of the number of days until patient received test results (top) and
number of times a message related to a PHE test result was handled by care team staff (bottom).
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Figure 3 Patient survey answer to question “It is important to me that before my examination, I have appropriate tests ahead of time
so results are available for discussion face-to-face with my provider.”
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Page 6 of 8absolute increase in number of tests ordered for the
usual care group compared to the pre-orders group (p =
0.001) and represented a 40% relative increase over the
number of tests ordered by the pre-orders group.
Discussion
In this study, we were able to demonstrate a pre-orders
process that was responsive to the desires of patients,
universally acceptable to physicians, sustainable, and
only took a few minutes of time to accomplish by ancil-
lary staff. To our knowledge, this is the first study to
quantify the impact of such a process on test ordering
before and after the PHE and the time cost involved.
The pre-order process is both a patient and provider
satisfier. It should be noted that this process was com-
pletely voluntary for all patients and providers. The
acceptance rate was close to 90% for patients and 100%
for providers. The high acceptance rate by patients is
consistent with our satisfaction survey which showed
the majority of patients preferred to have tests ordered
in advance of their periodic health examination. Coming
in for tests in advance of the PHE may have posed some
inconvenience for some patients. However, the high
patient compliance, demonstrated by the lab completion
rate of 87.8% suggests that they perceive this process as
added value to their PHE visit. Although we did not
perform a provider satisfaction survey, the 100% volun-
tary participation by providers, which has been sus-
tained, speaks for itself as an indicator of provider
satisfaction with the process.
Providers were given a large degree of autonomy to
modify the pre-orders template. We feel that the auton-
omy was important to achieve such high provider buy-
in. When the process was initially rolled out as a single
standardized template, it quickly became apparent that
providers desired the flexibility to customize the tem-
plate to allow for minor differences in practice style.
Once the process was adapted to allow providers the
autonomy to make minor changes to the template, all
providers embraced the process and have continued to
do so.
O u rd a t as u g g e s t ss o m er e a s o n sa st ow h yt h ep r e -
orders acceptance rate is high among patients and pro-
viders. A large percentage of patients had abnormal test
results. With this process, patients are able to benefit
from face-to-face discussion of results directly with their
provider. Previously, most patients would have received
test results by telephone from a nurse. This would often
require additional information for the patient from the
provider. We know from a previous study in our patient
population that patients prefer to receive tests results
directly from their provider [10]. One would expect this
to be even more important when tests results are abnor-
mal. A face-to-face discussion also allows for
development of a patient-centered plan to manage
results of abnormal tests.
Although this process did not eliminate the need for
additional orders at the time of the PHE, 29% of the
patients required no further tests ordered. The provider
has more time to focus discussion on specific patient
concerns instead of ordering routine tests. The patient
is able to be involved in his own care. This process is
very much in line with how a patient centered medical
home should function. The provider has more time dur-
ing the PHE to be perceived as the coordinator of care,
rather than merely reporting results by telephone at a
later time.
The importance of addressing the patient face-to-face
with abnormal results and when ordering consultations
should not be underestimated with this process. Not
only does the patient have the opportunity to question
the doctor about further tests and consultations, the
doctor in turn, is able to fulfill the role expected of
them in the medical home model by visibly showing the
patient their active role in coordinating care. Our pro-
cess also demonstrates patient centric team based care
coordination prior to the office visit. Even before the
patient comes to the PHE, the patient is aware that tests
are ordered customized to their particular needs, further
establishing the medical home model in the mind of the
patient.
Although this process could be generalized to other
practices, it is possible that patient acceptance may not
be as high. For example, it may be more inconvenient to
young, healthy patients that are more likely to have nor-
mal test results. For those with normal test results, the
value added by face-to-face discussion would likely be
less. For those populations having mostly normal results,
it may be more acceptable to have tests done on the
same day after the PHE, with the normal results
reported by telephone or by electronic means. Further
study is needed to determine whether the pre-orders
process would be as desirable in other population
groups.
This study had limitations. Our only control group is
historical and the number of face-to-face discussions
about PHE tests were quantifiable and was zero unless
the provider scheduled an additional visit. Telephone
calls for test results were not measured for the interven-
tion or control group. We did not fully analyze the
downstream cost of the pre-orders process. However,
we think that the 4-to-7 minute time taken by the LPN
to complete the pre-orders process pays for itself by a
decrease in downstream rework done both by the provi-
der and the nurse. A future study could look specifically
at the start to finish work required for the pre-orders
process compared to ordering at the time of the PHE.
Although we are able to add many laboratory tests to
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Page 7 of 8stored serum, these tests must be run within 7 days of
the original blood draw. Therefore, not all tests can be
run on stored serum.
Conclusion
In conclusion, we successfully implemented a pre-order
process to improve the quality of the PHE visit in an
internal medicine primary care practice using a standar-
dized approach allowing for provider autonomy. It was
readily implemented by LPNs with minimal training and
was accepted by patients and providers. The pre orders
process creates more face-to-face opportunity for the
provider to engage in patient centric activity which is
necessary in the medical home model.
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